Everolimus in Combination With Cyclosporine Microemulsion in de Novo Renal Transplant Recipients

NCT01276457 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

223

Enrollment

INDUSTRY

Sponsor class

Conditions

Transplantation Infection

Interventions

DRUG: Everolimus 0.25 and 0.75 mg tablets
DRUG: Cyclosporine very low dose (150-300 ng/mL) microemulsion
DRUG: Cyclosporine low dose (350-500 ng/mL) microemulsion

Sponsor

Novartis Pharmaceuticals